Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-09 @ 4:40 PM
Study NCT ID:
NCT02917720
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-22
First Post:
2016-03-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients
Sponsor:
European LeukemiaNet
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
ELN-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None